Chemoprevention of colorectal cancer
โ Scribed by Yoshiro Niitsu; Tetsuji Takayama; Koji Miyanishi; Atsushi Nobuoka; Tsuyoshi Hayashi; Takehiro Kukitsu; Kunihiro Takanashi; Hirotoshi Ishiwatari; Tomoyuki Abe; Takahiro Kogawa; Minoru Takahashi; Takuya Matsunaga; Junji Kato
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 239 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Understanding of the neoplastic events involved in heritable colorectal cancer syndromes is increasing at the molecular and clinical levels. This knowledge is foundational to cancer chemoprevention, which attempts to inhibit or reverse the tumorigenic process through pharmacologic interventions appl
Colorectal cancer is a significant cause of morbidity and mortality in industrialized societies and the second most frequent cause of cancer death in the United States. Surrogate endpoint biomarkers are gaining wide acceptance in early diagnosis and short-term cancer chemoprevention trials in place